NPC's Chief Science Officer to Speak at DIA 2012 Annual Meeting Executive Session
NPC Chief Science Officer Dr. Robert Dubois will speak during the “DIA 2012 Executive Session: Pioneering Partnerships” at the Drug Information Association’s Annual Meeting on June 26 at 10 a.m. Dubois' session, “Collaborative Research with Members of the Payer Community,” will focus on the power of the payer as the crucial emerging factor in the potential commercial success of pharmaceutical products.
Other panelists in this executive session include:
NPC Chief Science Officer Dr. Robert Dubois will speak during the “DIA 2012 Executive Session: Pioneering Partnerships” at the Drug Information Association’s Annual Meeting on June 26 at 10 a.m. Dubois' session, “Collaborative Research with Members of the Payer Community,” will focus on the power of the payer as the crucial emerging factor in the potential commercial success of pharmaceutical products.
Other panelists in this executive session include:
- Dr. Paul Chew, Senior Vice-President, Chief Science Officer, Chief Medical Officer, Sanofi
- Dr. Felix Frueh, President, Medco Research Institute, Medco Health Solutions, Inc.
- Dr. Steven J. Romano, MD, SVP, Medicines Development Group Head Primary Care Business Unit, Pfizer, Inc.
- George Maliekal, Senior Director, Business Development and Licensing, Abbott Molecular
This is a private program being held in conjunction with DIA's Annual Meeting. For more information on how to attend, view the DIA website.